Ken Cunningham Cunningham
Director/Board Member at VERONA PHARMA PLC
Net worth: 1 M $ as of 2024-03-30
Profile
Kenneth Thomas Cunningham is currently the Non-Executive Chairman at Medherant Ltd., a Non-Executive Director at Xention Pharma Ltd., an Independent Non-Executive Director at Verona Pharma Plc, a Non-Executive Director at Sunergos Innovations Ltd., a Non-Executive Director at Abzena Holdings Us LLC, and a Member at The Royal College of Physicians.
Previously, he served as the Chief Executive Officer at Sosei R&D Ltd.
from 2001 to 2005.
He also held positions as the Non-Executive Chairman at Prosonix Ltd., the Executive Chairman at PolyTherics Ltd., the Non-Executive Chairman at Abzena Ltd.
from 2010 to 2018, and the Director at SkyePharma Plc in 2010.
Additionally, he worked as the Medical Director at Glaxo Wellcome Plc, the Director at Xention Ltd.
from 2005 to 2016, the Vice President-European Affairs at ALZA Corp., the Vice President-Clinical Development at SEQUUS Pharmaceuticals, Inc., and as a Principal at Warner Lambert (UK) Ltd.
Dr. Cunningham holds a doctorate degree from Imperial College London.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VERONA PHARMA PLC
0.11% | 2023-04-27 | 532,672 ( 0.11% ) | 1 M $ | 2024-03-30 |
Ken Cunningham Cunningham active positions
| Companies | Position | Start |
|---|---|---|
| VERONA PHARMA PLC | Director/Board Member | 2015-09-09 |
| Sunergos Innovations Ltd. | Director/Board Member | - |
Medherant Ltd.
 Medherant Ltd. Pharmaceuticals: MajorHealth Technology Medherant Ltd. develops transdermal drug delivery patches. It offers transdermal drug patches for skin surface and are being used increasingly for pharmaceutical products such as analgesics, alzheimer's, smoking cessation, and hormone therapy. The company was founded by David Haddleton on April 2, 2014 and is headquartered in Coventry, the United Kingdom. | Chairman | 2017-02-05 |
Xention Pharma Ltd.
 Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom. | Director/Board Member | - |
| The Royal College of Physicians | Corporate Officer/Principal | - |
| Abzena Holdings Us LLC | Director/Board Member | 2020-12-31 |
Former positions of Ken Cunningham Cunningham
| Companies | Position | End |
|---|---|---|
| ABZENA PLC | Chairman | 2018-09-30 |
Xention Ltd.
 Xention Ltd. Pharmaceuticals: MajorHealth Technology Part of Xention Pharma Ltd., Xention Ltd. is a British company that develops and researches drugs. The private company is based in Newmarket, UK. Xention was founded in 2002. | Director/Board Member | 2016-06-29 |
| SKYEPHARMA PLC | Chief Executive Officer | 2010-09-29 |
| ░░░░░ ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Ken Cunningham Cunningham
| Imperial College London | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| VERONA PHARMA PLC | Health Technology |
| Private companies | 14 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
SEQUUS Pharmaceuticals, Inc.
 SEQUUS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SEQUUS Pharmaceuticals, Inc. is based in Menlo Park, CA. Part of Johnson & Johnson, SEQUUS Pharmaceuticals, Inc. is a company that markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases. SEQUUS Pharmaceuticals was acquired by ALZA Corp., part of Johnson & Johnson from June 22, 2001 on March 16, 1999 for $658.03 million. | Health Technology |
SkyePharma Plc
 SkyePharma Plc Pharmaceuticals: OtherHealth Technology SkyePharma Plc engaged in the provision of pharmaceutical business. It involved in development and supply of pharmaceutical products. The company was founded by Ian Roderick Gowrie-Smith on August 18, 1910 and was headquartered in London, the United Kingdom. | Health Technology |
| Glaxo Wellcome Plc | Health Technology |
Xention Pharma Ltd.
Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom. | Health Technology |
Warner Lambert (UK) Ltd.
 Warner Lambert (UK) Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Warner Lambert (UK) Ltd. is a manufacturer and wholesaler of pharmaceuticals and over the counter medicines. The private company is based in Eastleigh, UK. | Health Technology |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Health Technology |
Prosonix Ltd.
 Prosonix Ltd. Pharmaceuticals: MajorHealth Technology Prosonix Ltd. engages in the provision of inhaled respiratory medicines. The company was founded by Andre James Bush and David Hipkiss in 2006 and is headquartered in Oxford, the United Kingdom. | Health Technology |
PolyTherics Ltd.
 PolyTherics Ltd. Pharmaceuticals: MajorHealth Technology PolyTherics Ltd. develops biomedical polymers for therapeutic applications. The company was founded by Antony Godwin, Sunil Shaunak and Steve Brocchini in 2001 and is headquartered in Babraham, the United Kingdom. | Health Technology |
Xention Ltd.
Xention Ltd. Pharmaceuticals: MajorHealth Technology Part of Xention Pharma Ltd., Xention Ltd. is a British company that develops and researches drugs. The private company is based in Newmarket, UK. Xention was founded in 2002. | Health Technology |
Abzena Ltd.
 Abzena Ltd. BiotechnologyHealth Technology Abzena Ltd. engages in the provision of proprietary technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It offers antibody discover and candidate screening, immunology and immunogenicity assessment, antibody and protein engineering, bio conjugation, custom synthesis of cytotoxic payloads, reagents, and other small molecules, manufacture of payload linkers, development of manufacturing cell lines, and manufacture of biopharmaceuticals. The company was founded by Sunil Shaunak in 2001 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Medherant Ltd.
Medherant Ltd. Pharmaceuticals: MajorHealth Technology Medherant Ltd. develops transdermal drug delivery patches. It offers transdermal drug patches for skin surface and are being used increasingly for pharmaceutical products such as analgesics, alzheimer's, smoking cessation, and hormone therapy. The company was founded by David Haddleton on April 2, 2014 and is headquartered in Coventry, the United Kingdom. | Health Technology |
| Sunergos Innovations Ltd. | |
| Abzena Holdings Us LLC |
- Stock Market
- Insiders
- Ken Cunningham Cunningham
